Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study

Go back to Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study
Aethlon Medical, Inc. (NASDAQ: AEMD) Delayed: 2.72 -0.06 (2.16%)
Previous Close $2.78    52 Week High $9.09 
Open $2.73    52 Week Low $4.02 
Day High $2.87    P/E N/A 
Day Low $2.65    EPS $-0.05 
Volume 27,280